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Acne can cause substantial distress, 
decreased self-confidence and increased 
rates of depression and suicidal ideation.1 
Topical and oral antibiotics are commonly 
used to treat acne, due to both antimicrobial 
and anti-inflammatory mechanisms of 
action, but they are not always effective 
and alternatives are available.2 Whereas 
topical antibiotics predispose to overgrowth 
of antibiotic resistant bacteria on treated 
skin sites, oral antibiotics increase the 
numbers of resistant bacteria not only 
on the skin but at all body sites with 
resident commensal microflora. Examples 
include overgrowth of resistant strains of 
Propionibacterium acnes 3 and coagulase-
negative staphylococci on the skin4 as well 
as coliforms in the gut. Resistance emerges 
not only in treated patients but also in close 
contacts.3,4 
A strong case has been made for 
reducing antibiotic prescribing in primary 
care but relatively little emphasis has been 
placed on antibiotic prescribing for acne.5 
However, skin conditions account for 8% 
of primary care antibiotic prescribing and 
there is rising concern about ‘collateral 
damage to the steady-state microbiome’ of 
long-term antibiotic use in young people.3
A recent analysis of the Clinical 
Practice Research Datalink (CPRD) 
examined primary care consultations 
and prescriptions administered for acne.6 
This suggested that GPs prescribe oral 
antibiotics at 31% of first consultations 
for acne,6 though it is not clear whether 
this is due to GP prescribing habits or 
pressure from patients. Over 90% of acne is 
managed in primary care in the UK7 placing 
primary care clinicians in a key position to 
address the problem of rising antimicrobial 
resistance fuelled by antibiotic prescriptions 
for acne. 
EFFECTIVE NON-ANTIBIOTIC 
ALTERNATIVES 
The aetiology of acne is complex. Though P. 
acnes is strongly implicated in pathogenesis, 
acne is not an infection and effective 
antimicrobials do not eliminate P. acnes 
from the skin. A primary defect in sebum 
production triggers hyperproliferation 
of follicular keratinocytes resulting in 
inflammation via multiple pathways.8 The 
relative importance of antibacterial versus 
anti-inflammatory actions of antibiotics in 
the management of acne remains unclear. 
Benzoyl peroxide (available over-the-
counter in many countries, including 
the UK) is an effective non-antibiotic 
antimicrobial agent that can be used alone 
or in addition to antibiotics. It acts as a 
bactericidal agent that is equally effective 
against antibiotic resistant and susceptible 
strains of P. acnes and can also reduce 
the development of resistance within the 
resident skin microflora. It has limited 
impact at controlling selective pressure 
from oral antibiotics at body sites other 
than the area of application.
Topical retinoids, such as adapalene 
(Differin®), isotretinoin (Isotrex®) and 
tretinoin, act on abnormal keratinisation 
and also have anti-inflammatory properties. 
They are a potential skin irritant, which can 
lead to early abandonment of treatment 
unless appropriate advice to mitigate this 
is given.1 
Box 1 provides a summary of treatment 
guidelines and Box 2 contains resources 
providing information for patients, including 
advice on mitigating local reactions to 
topical agents.
For some women, combined oral 
contraceptives (particularly 3rd generation) 
or co-cyprindiol (Dianette®) can be effective 
alternatives to antibiotics, particularly 
when combined with topical treatments.9 
However, co-cyprindiol should be 
discontinued three to four menstrual cycles 
after the acne has resolved.10 
HOW TO AVOID ANTIBIOTIC RESISTANCE 
The UK guideline suggests that either 
benzoyl peroxide or a topical retinoid, 
such as adapalene (Differin), should be 
used first line.10 For moderate acne that is 
localised, a fixed dose combination topical 
product is recommended when benzoyl 
peroxide or topical retinoid monotherapy 
is ineffective. Oral antibiotics with topical 
benzoyl peroxide are recommended if the 
acne is more widespread or risk factors (for 
example, scarring) are present.
Three recently published evidence-
based guidelines from the US, Canada, 
and Europe agree with UK guideline in 
recommending that neither topical 
nor oral antibiotics should be used as 
monotherapy.11–13 Though the use of fixed-
dose combination of benzoyl peroxide/
adapalene (Epiduo®) has increased in 
recent years, combination clindamycin/
benzoyl peroxide (Duac®), and erythromycin 
(Zineryt®) remain by far the most commonly 
prescribed topical preparations for acne in 
England and Wales.14 Rates of resistance to 
erythromycin and clindamycin in P. acnes 
isolates from countries that use topical 
antibiotics for acne extensively vary from 
45% to 91%, strongly implicating topical use 
in the emergence of resistance.3
There have been few head-to-head 
comparisons of topical therapies including 
fixed dose combinations versus oral 
antibiotics so their comparative efficacies, 
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Box 1. Summary of acne vulgaris treatment guidance1
First-line therapy •  Single non-antibiotic topical drug in people with limited acne which is mild 
and unlikely to scar: benzoyl peroxide or a retinoid, for example, adapalene 
(Differin®), isotretinoin (Isotrex®) or tretinoin.
Second-line therapy •  Fixed dose combination topical retinoid with benzoyl peroxide (Epiduo®) or 
fixed dose combination topical antibiotic with benzoyl peroxide (for example, 
Duac®) or topical retinoid 
Third-line therapy  • An oral antibiotic or (in females) a combined oral contraceptive or co-cyprindiol 
  (Dianette®). 
  For oral antibiotics: 
  • Limit to short periods (ideally 3–4 months) 
  • Do not use as monotherapy 
  • Use alongside topical retinoids to expedite response  
  • Co-prescribe benzoyl peroxide-containing product (limits resistance at site of 
      application only) 
  • Avoid concurrent use of oral and topical antibiotics
Maintenance therapy  • Use topical retinoids, with benzoyl peroxide added if needed 
 • Avoid antibiotics
1Adapted from NICE Clinical Knowledge Summary guideline on acne vulgaris (2014).10
especially in moderate acne, are not 
certainly known. Until such information 
becomes available, it would seem 
preferable to avoid oral antibiotics, except 
when justified by severity, distribution of 
lesions, scarring or other risk factors. 
Expert consensus and current guidelines 
recommend keeping courses of antibiotics 
relatively short, with a maximum duration 
of 3–4 months. While the acne may not be 
cleared after this time in all patients, most 
should be sufficiently improved to switch 
to a topical non-antibiotic maintenance 
regimen that will continue to reduce the 
number of lesions and prevent recurrence.
Consideration of earlier referral to 
secondary care can be considered in 
preference to extending treatment duration 
with antibiotics or trying various different 
ones. Oral isotretinoin may avoid the need for 
multiple courses of antibiotics and, despite 
recent concerns expressed in the media 
about rising rates of prescribing, reviews 
have not shown an increase in depression 
following initiation of isotretinoin.1 However, 
prescriptions for oral isotretinoin are still 
administered under the supervision of a 
consultant dermatologist due to potentially 
serious adverse effects that include the 
very high risk of teratogenicity.
SUMMARY
Despite the continued popularity of 
antibiotics for acne, effective alternatives 
are available to minimise their use and 
reduce the impact of acne prescribing on 
the spread of antibiotic resistant bacteria. 
Antibiotics still have an important role to 
play, especially in managing more severe 
inflammatory acne, but only as part of a 
regimen that includes benzoyl peroxide. In 
mild to moderate acne, topical retinoids and 
benzoyl peroxide alone or in combination 
are effective if used regularly. Advice on 
minimising skin irritation may increase 
adherence.
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Box 2. Resources to promote effective use of topical treatments 
Resource Advice
NHS Choices  Includes a guide to choosing different treatments 
www.nhs.uk/Conditions/Acne  
Patient.co.uk Includes advice that treatments may take 4-6 weeks to  
patient.info/health/acne-leaflet work. Includes basic advice about dealing with side effects
British Association of Dermatologists Comprehensive advice, including advice that treatments 
bad.org.uk/for-the-public/patient- may take 4-6 weeks to work.  
information-leaflets/acne Includes basic advice about dealing with side effects.
Healthtalk.org More extensive advice on all aspects of acne treatments 
healthtalk.org/young-peoples-experiences including advice on dealing with common side effects. 
/acne Includes interviews with young people with acne.
